Adial Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Adial Pharmaceuticals Inc share price today is $1.93, up 6.95%. The stock opened at $1.98 against the previous close of $1.87, with an intraday high of $2.07 and low of $1.975.

Adial Pharmaceuticals Inc Share Price Chart

Adial Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Adial Pharmaceuticals Inc Share Price Performance

$1.93 0.0695(6.95%) ADIL at 23 Mar 2026 11:53 AM Biotechnology
Lowest Today 1.975
Highest Today 2.07
Today’s Open 1.98
Prev. Close 1.87
52 Week High 21.38
52 Week Low 1.54
Day’s Range: Low 1.975 High 2.07
52-Week Range: Low 1.54 High 21.38
1 day return -
1 Week return +5.4
1 month return -22.61
3 month return +705.45
6 month return +467.52
1 year return +186.76
3 year return -80.63
5 year return -96.89
10 year return -

Adial Pharmaceuticals Inc Institutional Holdings

Citadel Advisors Llc 0.79

Vanguard Group Inc 0.56

Geode Capital Management, LLC 0.56

Fidelity Extended Market Index 0.48

NT Ext Equity Mkt Idx Fd - L 0.24

Manchester Capital Management LLC 0.17

BlackRock Inc 0.10

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.09

Blackrock Extended Mkt Fund CF 0.07

UBS Group AG 0.07

Extended Equity Market Fund K 0.06

TWO SIGMA SECURITIES, LLC 0.06

Susquehanna International Group, LLP 0.04

Fidelity Series Total Market Index 0.03

Vanguard Institutional Extnd Mkt Idx Tr 0.03

Fidelity Total Market Index 0.03

Spartan Total Market Index Pool G 0.02

Extended Equity Market Fund M 0.01

Tower Research Capital LLC 0.00

SBI Securities Co Ltd 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Bank of America Corp 0.00

Wells Fargo & Co 0.00

SSgA U.S. Total Market Index Strategy 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Abound Wealth Management 0.00

Citigroup Inc 0.00

HRT FINANCIAL LLC 0.00

Jane Street Group LLC 0.00

Morgan Stanley - Brokerage Accounts 0.00

Private Management Group Inc 0.00

Stone House Investment Management, LLC 0.00

Two Sigma Investments LLC 0.00

Adial Pharmaceuticals Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Adial Pharmaceuticals Inc Fundamentals

Market Cap 2.86 M

PB Ratio 0.5061

PE Ratio 0.0

Enterprise Value -3.21 M

Total Assets 6.67 M

Volume 177909

Adial Pharmaceuticals Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-6069703 -6.1M, FY22:-12731416 -12.7M, FY21:-19423326 -19.4M, FY20:-10860495 -10.9M, FY19:-8591429 -8.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-141 -0.0M, Q2/2025:-141 -0.0M, Q1/2025:-141 -0.0M, Q3/2024:null 0.0M, Q2/2024:-141 -0.0M

Quarterly Net worth Q3/2025:-1793651 -1.8M, Q2/2025:-1958556 -2.0M, Q1/2025:-2228801 -2.2M, Q3/2024:-2191803 -2.2M, Q2/2024:-2458298 -2.5M

About Adial Pharmaceuticals Inc & investment objective

Company Information Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Mr. Cary John Claiborne MBA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Adial Pharmaceuticals Inc FAQs

What is the share price of Adial Pharmaceuticals Inc today?

The current share price of Adial Pharmaceuticals Inc is $1.93.

Can I buy Adial Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Adial Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Adial Pharmaceuticals Inc shares in India?

You can easily invest in Adial Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Adial Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Adial Pharmaceuticals Inc?

Adial Pharmaceuticals Inc has a market cap of $2.86 M.

In which sector does Adial Pharmaceuticals Inc belong?

Adial Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Adial Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Adial Pharmaceuticals Inc?

The PE ratio of Adial Pharmaceuticals Inc is N/A and the PB ratio is 0.51.